239 related articles for article (PubMed ID: 26379627)
1. FGF21 and Cardiac Physiopathology.
Planavila A; Redondo-Angulo I; Villarroya F
Front Endocrinol (Lausanne); 2015; 6():133. PubMed ID: 26379627
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 21 protects the heart from oxidative stress.
Planavila A; Redondo-Angulo I; Ribas F; Garrabou G; Casademont J; Giralt M; Villarroya F
Cardiovasc Res; 2015 Apr; 106(1):19-31. PubMed ID: 25538153
[TBL] [Abstract][Full Text] [Related]
3. Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases.
Cheng P; Zhang F; Yu L; Lin X; He L; Li X; Lu X; Yan X; Tan Y; Zhang C
J Diabetes Res; 2016; 2016():1540267. PubMed ID: 27247947
[TBL] [Abstract][Full Text] [Related]
4. The protective effect of fibroblast growth factor-21 in alcoholic cardiomyopathy: a role in protecting cardiac mitochondrial function.
Ferrer-Curriu G; Guitart-Mampel M; Rupérez C; Zamora M; Crispi F; Villarroya F; Fernández-Solà J; Garrabou G; Planavila A
J Pathol; 2021 Feb; 253(2):198-208. PubMed ID: 33125701
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 21 protects against cardiac hypertrophy in mice.
Planavila A; Redondo I; Hondares E; Vinciguerra M; Munts C; Iglesias R; Gabrielli LA; Sitges M; Giralt M; van Bilsen M; Villarroya F
Nat Commun; 2013; 4():2019. PubMed ID: 23771152
[TBL] [Abstract][Full Text] [Related]
6. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21.
Iglesias P; Selgas R; Romero S; Díez JJ
Eur J Endocrinol; 2012 Sep; 167(3):301-9. PubMed ID: 22740503
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 21: a promising therapeutic target in obesity-related diseases.
Cheung BM; Deng HB
Expert Rev Cardiovasc Ther; 2014 Jun; 12(6):659-66. PubMed ID: 24697521
[TBL] [Abstract][Full Text] [Related]
8. TNF-α represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway.
Díaz-Delfín J; Hondares E; Iglesias R; Giralt M; Caelles C; Villarroya F
Endocrinology; 2012 Sep; 153(9):4238-45. PubMed ID: 22778214
[TBL] [Abstract][Full Text] [Related]
9. FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism.
Joki Y; Ohashi K; Yuasa D; Shibata R; Ito M; Matsuo K; Kambara T; Uemura Y; Hayakawa S; Hiramatsu-Ito M; Kanemura N; Ogawa H; Daida H; Murohara T; Ouchi N
Biochem Biophys Res Commun; 2015 Mar; 459(1):124-30. PubMed ID: 25712519
[TBL] [Abstract][Full Text] [Related]
10. Effects of fibroblast growth factor 21 on the heart.
Tanajak P; Chattipakorn SC; Chattipakorn N
J Endocrinol; 2015 Nov; 227(2):R13-30. PubMed ID: 26341481
[TBL] [Abstract][Full Text] [Related]
11. Sirt1 acts in association with PPARα to protect the heart from hypertrophy, metabolic dysregulation, and inflammation.
Planavila A; Iglesias R; Giralt M; Villarroya F
Cardiovasc Res; 2011 May; 90(2):276-84. PubMed ID: 21115502
[TBL] [Abstract][Full Text] [Related]
12. Serum fibroblast growth factor-21 levels are associated with carotid atherosclerosis independent of established cardiovascular risk factors.
Chow WS; Xu A; Woo YC; Tso AW; Cheung SC; Fong CH; Tse HF; Chau MT; Cheung BM; Lam KS
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2454-9. PubMed ID: 23887638
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.
Woo YC; Xu A; Wang Y; Lam KS
Clin Endocrinol (Oxf); 2013 Apr; 78(4):489-96. PubMed ID: 23134073
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiological roles of FGF signaling in the heart.
Itoh N; Ohta H
Front Physiol; 2013 Sep; 4():247. PubMed ID: 24046748
[TBL] [Abstract][Full Text] [Related]
15. Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes.
Xiao Y; Liu L; Xu A; Zhou P; Long Z; Tu Y; Chen X; Tang W; Huang G; Zhou Z
Cardiovasc Diabetol; 2015 Jun; 14():72. PubMed ID: 26047614
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 21 (FGF21) ameliorates collagen-induced arthritis through modulating oxidative stress and suppressing nuclear factor-kappa B pathway.
Yu Y; Li S; Liu Y; Tian G; Yuan Q; Bai F; Wang W; Zhang Z; Ren G; Zhang Y; Li D
Int Immunopharmacol; 2015 Mar; 25(1):74-82. PubMed ID: 25601498
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 21 in heart failure.
Tucker W; Tucker B; Rye KA; Ong KL
Heart Fail Rev; 2023 Jan; 28(1):261-272. PubMed ID: 36028609
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice.
Lin Z; Pan X; Wu F; Ye D; Zhang Y; Wang Y; Jin L; Lian Q; Huang Y; Ding H; Triggle C; Wang K; Li X; Xu A
Circulation; 2015 May; 131(21):1861-71. PubMed ID: 25794851
[TBL] [Abstract][Full Text] [Related]
19. PPARalpha is a key regulator of hepatic FGF21.
Lundåsen T; Hunt MC; Nilsson LM; Sanyal S; Angelin B; Alexson SE; Rudling M
Biochem Biophys Res Commun; 2007 Aug; 360(2):437-40. PubMed ID: 17601491
[TBL] [Abstract][Full Text] [Related]
20. Understanding the Physiology of FGF21.
Fisher FM; Maratos-Flier E
Annu Rev Physiol; 2016; 78():223-41. PubMed ID: 26654352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
